Overview

A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Status:
RECRUITING
Trial end date:
2026-07-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy of VRB-101 for body weight reduction compared to placebo in participants who have obesity or overweight with weight-related comorbidities.
Phase:
PHASE2
Details
Lead Sponsor:
Verdiva Bio Dev Limited